| Grade1/2 | Grade3/4 | |
|---|---|---|
| Oxaliplatin (n = 58, 73.4%) | ||
| Neurotoxicity | 86.2% | 5.2% |
| Nausea & Vomiting | 27.6% | |
| 5-Fluorouracil (n = 47, 59.4%) | ||
| Neutropenia | 27.6% | 34.1% |
| Hand-Foot Syndrome | 44.7% | 2.1% |
| Mucositis | 61.7% | 4.2% |
| Diarrhoea | 38.2% | 6.4% |
| Capecitabine (n = 31, 39.2%) | ||
| Hand-Foot Syndrome | 32.3% | 9.7% |
| Mucositis | 29.1% | |
| Diarrhoea | 22.6% | 9.7% |
| Bevacizumab (n = 44, 55.7%) | ||
| Hypertension | 15.9% | 11.4% |
| Proteinuria | 63.7% | 4.5% |
| Cetuximab/Panitumumab (n = 12, 15.2%) | ||
| Paronychia | 75% | |
| Cutaneous rash | 75% | 25% |